Status:
COMPLETED
Post-conditioning to Reduce Infarct Size
Lead Sponsor:
Minneapolis Heart Institute Foundation
Collaborating Sponsors:
Society for Cardiovascular Angiography and Interventions
Conditions:
Myocardial Infarction
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
When angioplasty (PTCA) and stenting of the blood vessels of the heart is the treatment for a Heart Attack, there is damage to the heart muscle that is caused by the sudden opening of the blood vessel...
Eligibility Criteria
Inclusion
- Age ≥ 18 \< 80
- Able to give informed consent
- 100% occlusion of a major epicardial vessel with TIMI 0 Flow
Exclusion
- Significant collateral blood flow to the distal vasculature of the occluded vessel.
- Previous CABG
- Previous q-wave myocardial infarction in the same territory
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2010
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT00755469
Start Date
September 1 2008
End Date
August 1 2010
Last Update
December 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abbott Northwestern Hospital
Minneapolis, Minnesota, United States, 55407